Ionis achieves successful Phase 3 trial to treat rare diseases
December 19, 2016Manufacturing and Production, Research and Development Akcea, Ionis, rare disease
Ionis Pharmaceutial announced that the results of a Phase 3 trial into its treatment for hypertriglyceridemia met its primary endpoint. …
AZ secures rights from Ionis for first-ever antisense KRAS cancer drug in $165m deal
December 19, 2016Research and Development, Sales and Marketing AstraZeneca, Ionis, KRAS
AstraZeneca has paid a $28 million milestone payment in its partnership with Ionis Pharmaceuticals over the licensing rights to anticancer …
Robert Ross joins Surface Oncology as chief medical officer
December 19, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Surface Oncology, bluebirdbio
Surface Oncology, an immuno-oncology company developing immunotherapies that target the tumour microenvironment, has announced the appointment of Robert Ross as …
Insider interview: NICE discusses its planned ‘fast-track’ appraisal process
December 19, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, UK, approval
Jenniffer Prescott, associate director of planning, operations and topic selection, answers questions on NICE’s recent plans for a ‘fast-track’ appraisal …
FDA orders new label warnings over anaesthetics risk in children
December 19, 2016Research and Development, Sales and Marketing FDA, anaesthetics
The FDA has announced a new Drug Safety Communication for label warnings on general anaesthetic and sedation products because of …
Novartis acquires Ziarco adding to dermatology pipeline
December 19, 2016Sales and Marketing Novartis, Ziarco, eczema, oral
Novartis has announced that it will acquire UK-based Ziarco, to add Ziarco’s lead investigational oral treatment for moderate-to-severe eczema to …
FDA removes black box warning on Pfizer’s anti-smoking medication
December 19, 2016Medical Communications, Sales and Marketing GlaxoSmithKline, Pfizer, anti-smoking, nicotine, smoking
The FDA has decided to remove the “black box” warning upon Pfizer’s anti-smoking drug, Chantix, basing its decision upon the …
Mylan launches $300 generic EpiPen to calm pricing controversy
December 16, 2016Sales and Marketing Mylan, epipen
Mylan has launched a generic alternative to its flagship EpiPen auto-injector, a move to placate the outbreak of industry indignity …
Genentech announces Bill Anderson as new CEO
December 16, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bill Anderson, Genentech, Roche
Genentech, the biotech subsidiary of Roche, has announced that Genentech veteran, Ian Clark, will retire as CEO on 1 January. …
Nurofen maker hit by $6m fine over “misleading conduct”
December 16, 2016Sales and Marketing Nurofen, Reckitt Benckiser
After a case last year levied by the Australian Federal Court over “misleading conduct” concerning the marketing of its branded …
MSD-Gilead patent squabble ends in $2.54 billion verdict
December 16, 2016Medical Communications
A patent lawsuit between Gilead Sciences and MSD, known as Merck in the US, has resulted in MSD being awarded …
Top Ten most popular articles on Pharmafile.com this week
December 16, 2016Medical Communications biggest news, biggest stories, top 10, top 10 stories, top stories, top ten
Christmas is nearly here, but there isn’t much Christmas cheer to be had in the pharmaceutical industry. It’s been a …
Six generics companies hit by 20-state-strong lawsuit
December 16, 2016Medical Communications Heritage, Mylan, Teva
Following hot on the heels of yesterday’s news that a former CEO and president of Heritage Pharmaceuticals had been charged …
Actavis UK overcharged NHS with 12,000% price hike, watchdog says
December 16, 2016Medical Communications, Sales and Marketing Actavis, CMA, NHS
Actavis UK has been accused by the Competition and Markets Authority (CMA) of overcharging the NHS by selling its hydrocortisone …
Insider interview: NICE discusses its planned ‘fast-track’ appraisal process
December 16, 2016Medical Communications, Sales and Marketing NICE
Jenniffer Prescott, associate director of planning, operations and topic selection, answers questions on NICE’s recent plans for a ‘fast-track’ appraisal …
Bart de Strooper chosen as new director of UK Dementia Research Institute
December 15, 2016Bart de Strooper has been chosen as the new director of the UK Dementia Research Institute (UK DRI), and University …
First human trial of tau-targeting Alzheimer’s vaccine shows promise
December 15, 2016Medical Communications, Research and Development Alzheimer's
The latest in a succession of promising announcements surrounding Alzheimer’s R&D, researchers at the Karolinska Institutet in Stockholm, Sweden have …
GSK opens state-of-the-art global vaccine centre
December 15, 2016Manufacturing and Production, Medical Communications
GlaxoSmithKline has opened its new global vaccines R&D centre in Rockville, Maryland, to add to its two existing facilities in …
Pfizer’s next blockbuster given FDA approval
December 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, atopic dermatitis, eczema
Pfizer announced that it had received approval for its eczema treatment, Eucrisa, for patients of two years of age and …
Lonza in $5.5 billion deal to acquire Capsugel
December 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Capsugel, Lonza, acquistion
Lonza, the Basel-based supplier to the pharmaceutical, biotech and nutrition industry, has announced that it will acquire Capsugel for $5.5 …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
